Literature DB >> 837332

Economic status and survival of cancer patients.

J W Berg, R Ross, H B Latourette.   

Abstract

The relation of economic status to survival was studied for 39 kinds of cancer representing all types for which 60 or more indigent patients were seen in University of Iowa Hospital for primary care during the years 1940-1969. For every type the indigent patients had poorer survival than non-indigent patients. Quality of care would be eliminated as a major variable since a second group of "ward" patients of higher economic status was available for comparison and the differences were substantially greater between the two groups of teaching patients than between the "clinic pay" and "private" patients. Age differences and differences in stage of disease accounted for less than half of the survival deficits in the indigents. The two important problems were high mortality from causes other than cancer and excess cancer mortality not accounted for by stage differences, particularly among patients who should have had 5-year survival rates between 40 and 70%. In these patients cancer recurred more often and earlier among the indigent. We postulate host differences associated with poverty that could also account for much of the observed Black-White differences as well as some international differences in cancer survival rates.

Entities:  

Mesh:

Year:  1977        PMID: 837332     DOI: 10.1002/1097-0142(197702)39:2<467::aid-cncr2820390215>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

1.  Socioeconomic status and survival from soft-tissue sarcomas: a population-based study in northern Italy.

Authors:  G Ciccone; C Magnani; L Delsedime; P Vineis
Journal:  Am J Public Health       Date:  1991-06       Impact factor: 9.308

2.  Late-stage diagnosis of breast cancer in women of lower socioeconomic status: public health implications.

Authors:  T A Farley; J T Flannery
Journal:  Am J Public Health       Date:  1989-11       Impact factor: 9.308

3.  Development of a community cancer education program: the Forsyth County, NC cervical cancer prevention project.

Authors:  R Michielutte; M B Dignan; H B Wells; L D Young; D S Jackson; P C Sharp
Journal:  Public Health Rep       Date:  1989 Nov-Dec       Impact factor: 2.792

4.  Measuring social class differences in cancer patient survival: is it necessary to control for social class differences in general population mortality? A Finnish population-based study.

Authors:  P W Dickman; A Auvinen; E T Voutilainen; T Hakulinen
Journal:  J Epidemiol Community Health       Date:  1998-11       Impact factor: 3.710

5.  Social class and black-white differences in breast cancer survival.

Authors:  M T Bassett; N Krieger
Journal:  Am J Public Health       Date:  1986-12       Impact factor: 9.308

Review 6.  Variations in breast cancer treatment by patient and provider characteristics.

Authors:  J Z Ayanian; E Guadagnoli
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival.

Authors:  C S Thomson; D J Hole; C J Twelves; D H Brewster; R J Black
Journal:  J Epidemiol Community Health       Date:  2001-05       Impact factor: 3.710

Review 8.  Cancer patient survival by socioeconomic status in seven countries: a review for six common cancer sites [corrected].

Authors:  C T Schrijvers; J P Mackenbach
Journal:  J Epidemiol Community Health       Date:  1994-10       Impact factor: 3.710

9.  Social and biological factors in relation to survival among black vs. white women with breast cancer.

Authors:  B Valanis; J Wirman; V S Hertzberg
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

10.  Social factors, treatment, and survival in early-stage non-small cell lung cancer.

Authors:  H P Greenwald; N L Polissar; E F Borgatta; R McCorkle; G Goodman
Journal:  Am J Public Health       Date:  1998-11       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.